UK Supreme Court wrestles with plausibility and the pregabalin patent
The UK Supreme Court last week heard argument in Warner Lambert v Generics. Pfizer argued that plausibility should be an "evidential tool" not a "threshold test", while Actavis warned against the danger of over-broad speculative claims and "armchair patenting”
The UK Supreme Court last week heard patent case Warner Lambert v Generics, which concerns the drug pregabalin and the question of plausibility. This is an issue that has generated lots of discussion, and the Supreme Court should provide an answer...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.